Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Allergy Clin Immunol. 2019 Oct 8;145(1):127–139. doi: 10.1016/j.jaci.2019.09.018

Figure 5.

Figure 5.

Radar plots depicting changes in individual domains of the Asthma Severity Scoring System (ASSESS) at baseline and after intramuscular triamcinolone. Spikes correspond to individual participants responses. Panels B-D depict changes (mean ± SEM) in FEVi, ACQ7, and ACQ6 scores after triamcinolone in participants in whom ASSESS scores improved (≥2 point decrease), did not change, and worsened (≥2 point increase). **p<0.01